403 related articles for article (PubMed ID: 11881547)
1. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
Rao SK
Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
[TBL] [Abstract][Full Text] [Related]
2. Developing customer databases.
Rao SK; Shenbaga S
Mark Health Serv; 2000; 20(4):10-4. PubMed ID: 11209474
[TBL] [Abstract][Full Text] [Related]
3. Effective executive management in the pharmaceutical industry.
Tran H; Kleiner BH
J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
[TBL] [Abstract][Full Text] [Related]
4. The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?
Wellman-Labadie O; Zhou Y
Health Policy; 2010 May; 95(2-3):216-28. PubMed ID: 20036435
[TBL] [Abstract][Full Text] [Related]
5. Examining the applicability of market forecasting models to new pharmaceutical products.
Agrawal M; Calantone RJ
Health Mark Q; 1996; 13(4):17-31. PubMed ID: 10159642
[TBL] [Abstract][Full Text] [Related]
6. The undiscovered Argentine pharmaceutical market.
Felix PF; Thomas RK; Pol LG
Mark Health Serv; 2001; 21(4):12-6. PubMed ID: 11763647
[TBL] [Abstract][Full Text] [Related]
7. Preventing the premature death of relationship marketing.
Fournier S; Dobscha S; Mick DG
Harv Bus Rev; 1998; 76(1):42-4. PubMed ID: 10176918
[TBL] [Abstract][Full Text] [Related]
8. What can Johnson & Johnson do to remain a giant in the health care industry?
Carter T
J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
[TBL] [Abstract][Full Text] [Related]
9. Contextual marketing--the real business of the Internet.
Kenny D; Marshall JF
Harv Bus Rev; 2000; 78(6):119-25. PubMed ID: 11184966
[TBL] [Abstract][Full Text] [Related]
10. 'Get with the Program!': pharmaceutical marketing, symptom checklists and self-diagnosis.
Ebeling M
Soc Sci Med; 2011 Sep; 73(6):825-32. PubMed ID: 21835526
[TBL] [Abstract][Full Text] [Related]
11. Marketing to the consumer: perspectives from the pharmaceutical industry.
David C
Mark Health Serv; 2001; 21(1):5-11. PubMed ID: 11291513
[TBL] [Abstract][Full Text] [Related]
12. Business marketing: understand what customers value.
Anderson JC; Narus JA
Harv Bus Rev; 1998; 76(6):53-5, 58-65. PubMed ID: 10187246
[TBL] [Abstract][Full Text] [Related]
13. Entry decisions in the generic pharmaceutical industry.
Morton FM
Rand J Econ; 1999; 30(3):421-40. PubMed ID: 10558596
[TBL] [Abstract][Full Text] [Related]
14. Marketing decision support systems for strategy building.
Rao SK
Mark Health Serv; 2000; 20(2):14-8. PubMed ID: 11183424
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
Mahinka SP; Sanzo KM
Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
[No Abstract] [Full Text] [Related]
16. Need a new drug?
Gorman C
Time; 1995 Jul; 146(5):52. PubMed ID: 10144386
[No Abstract] [Full Text] [Related]
17. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery.
Findlay S
Mark Health Serv; 2002; 22(1):20-5. PubMed ID: 11881540
[TBL] [Abstract][Full Text] [Related]
18. Huckstering health.
Aufderheide P
Channels; 1985; 5(1):51-2. PubMed ID: 12267261
[TBL] [Abstract][Full Text] [Related]
19. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
Kros JF; Molis J
Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
[No Abstract] [Full Text] [Related]
20. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
Chodock R; Yolkut D; Connolly DR
Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
